<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[]]></title>
    <link>https://bmsv2016.sciencesconf.org/</link>
    <description><![CDATA[]]></description>
    <pubDate>Tue, 04 Oct 2016 08:20:52 +0200</pubDate>
    <image>
      <url>https://bmsv2016.sciencesconf.org//img/portal/sciencesconf.nb.png</url>
      <title><![CDATA[]]></title>
      <link>https://bmsv2016.sciencesconf.org/</link>
    </image>
    <generator>Zend_Feed</generator>
    <language>fr</language>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[Communications orales]]></title>
      <link>https://bmsv2016.sciencesconf.org/</link>
      <guid isPermaLink="false">1659</guid>
      <description><![CDATA[Communications orales SESSION 1: From anti-coagulant activities to heparin discovery, molecular mechanism and drug development 1 - Aurélien Alix 2 - Hélène Ledru 3 - Anne Robert 4 - Sylvia Colliec-Jouault SESSION 2: From heparin to heparan sulfate and the biology of other glycosaminoglycans 1 - Fabien Lecaille 2 - Kwok CFJ 3 - Sylvie Fournel Gigleux 4 - Jane Fisher]]></description>
      <pubDate>Mon, 03 Oct 2016 18:16:05 +0200</pubDate>
    </item>
  </channel>
</rss>
